跳至主要内容
临床试验/NCT00966056
NCT00966056已完成2 期

Comparative Study of Mitomycin C and Internal Nasal Septal Splint in the Treatment of Nasal Synechiae

Karnataka Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Recurrence or absence of synechiae

研究概览

简要总结

This study evaluates whether Mitomycin C is an effective alternative to septal splints in the treatment of nasal synechiae.

详细描述

Nasal synechiae is an important cause for the failure of many a nasal surgery. Septal splints have been widely used for the treatment of nasal synechiae, but are associated significant morbidity until removal. To the best of our knowledge there are no studies in literature comparing Mitomycin C with septal splints as an atraumatic alternative in the treatment of nasal synechiae. This is a preliminary study taken up to evaluate the therapeutic efficacy of Mitomycin C in the treatment of nasal synechiae.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with nasal mucosal synechiae due to surgical or non-surgical trauma

排除标准

  • Patients with nasal vestibular stenosis
  • Patients with nasal synechiae due to diseases like Hansen's disease, Syphilis, Rhinoscleroma, Atrophic Rhinitis etc.

研究组 & 干预措施

Mitomycin C

Active Comparator

Cases recruited into this arm receive topical application of mitomycin c (1mg/ml)following surgical synechiolysis

干预措施: Mitomycin C (Drug)

Teflon septal splint

Active Comparator

Cases recruited into this arm receive insertion of teflon internal nasal septal splint following surgical synechiolysis

干预措施: Teflon nasal septal splint (Device)

结局指标

主要结局

Recurrence or absence of synechiae

时间窗: 1 week, 1 month, 2 months

次要结局

  • Symptoms and complications(1 week, 1 month, 2 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Study of Mitomycin C and Nasal Splint to Treat Nasal... | 临床试验